首页 | 官方网站   微博 | 高级检索  
     

清胰汤加减治疗重症急性胰腺炎疗效研究
引用本文:张建茹,张 英,张 雨,卢利军.清胰汤加减治疗重症急性胰腺炎疗效研究[J].陕西中医,2022,0(9):1230-1233.
作者姓名:张建茹  张 英  张 雨  卢利军
作者单位:(1.秦皇岛市第二医院,河北 秦皇岛 066600; 2.空军第九八六医院第五门诊部,陕西 西安 710054)
摘    要:目的:分析清胰汤加减治疗重症急性胰腺炎(SAP)疗效及对血清炎症指标影响。方法:选取SAP患者86例,按随机数字表法分为研究组(n=43)、对照组(n=43)。对照组予生长抑素及连续性肾脏替代疗法(CRRT),研究组在对照组基础上予清胰汤加减治疗,两组均治疗1周。比较两组临床疗效、症状改善时间,治疗前后疾病严重程度、血清炎症指标、疾病相关因子。结果:研究组肛门排便恢复时间、腹痛消失时间、腹胀消失时间、发热消失时间、肠鸣音恢复时间均短于对照组,差异有统计学意义(均P<0.05)。治疗后,两组急性生理与慢性健康状况(APACHEⅡ)得分、全血白细胞计数(WBC)、血清活动性肠肽(VIP)、微管相关蛋白1轻链3(MAP1-LC3)、髓样细胞触发受体-1(TREM-1)、血清C反应蛋白(CRP)、血淀粉酶(AMS)水平均较治疗前降低,且研究组低于对照组,差异有统计学意义(均P<0.05)。治疗后,研究组总有效率高于对照组,差异有统计学意义(P<0.05)。结论:清胰汤加减联合CRRT治疗SAP效果较好,可促进临床症状消失、降低疾病严重程度,其机制可能与调节机体疾病相关因子水平,抑制炎症反应有关。

关 键 词:重症急性胰腺炎  清胰汤加减  连续性肾脏替代疗法  炎症反应  活动性肠肽  微管相关蛋白1轻链3

Clinical study on modified Qingyi decoction in treatment of patients with severe acute pancreatitis
ZHANG Jianru,ZHANG Ying,ZHANG Yu,LU Lijun.Clinical study on modified Qingyi decoction in treatment of patients with severe acute pancreatitis[J].Shaanxi Journal of Traditional Chinese Medicine,2022,0(9):1230-1233.
Authors:ZHANG Jianru  ZHANG Ying  ZHANG Yu  LU Lijun
Affiliation:(The Second Hospital of Qinhuangdao,Qinhuangdao 066600,China)
Abstract:Objective:To analyze efficacy of modified Qingyi decoction in the treatment of patients with severe acute pancreatitis(SAP)and effect of levels of serum inflammatory indexes.Methods:86 patients with SAP were divided into the study group(n=43)and the control group(n=43)by random number table method.The control group received somatostatin and continuous renal replacement therapy(CRRT)treatment,and the study group received the modified Qingyi decoction on the basis of the control group.Both groups were treated for one week.The clinical efficacy,symptom improvement time and disease severity,serum inflammatory indexes,disease-related factors before and after treatment were compared between the two groups.Results:The recovery time of anal defecation,abdominal pain,abdominal distension,fever and bowel sounds in the study group were all shorter than those in the control group(all P<0.05).After treatment,the score of acute physiology and chronic health status(APACHE Ⅱ),the levels of complete blood white blood cell(WBC),serum vasoactine intrestinal peptide(VIP),microtubule-associated protein 1 light chain 3(MAP1-LC3),triggering receptors expressed on myeloid cells-1(TREM-1),C-reactive protein(CRP)and amylase(AMS)in the study group were lower than those before treatment,and the study group were lower than those in the control group(all P<0.05).After treatment,the total effective rate in the study group was higher than that in the control group,difference statistically significant(P<0.05).Conclusion:Modified Qingyi decoction combined with CRRT has definite curative effect in the treatment of patients with SAP,which colud accelerate the disappearance of clinical symptoms and reduce the severity of disease,analysis related to the regulation of the level of the body's disease-related factors and the inhibition of inflammatory response.
Keywords:evere acute pancreatitis  Modified Qingyi decoction  Continuous renal replacement therapy  Inflammatory response  Vasoactine intrestinal peptide  Microtubule-associated protein 1 light chain 3
点击此处可从《陕西中医》浏览原始摘要信息
点击此处可从《陕西中医》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号